Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - TOTAL EQUITY
Total Equity FDMT - 4D Molecular Therapeutics, Inc.
308 M
LAST VALUE
86.74%
2 YEAR CAGR
67.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR